Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma

The First Affiliated Hospital of Xinxiang Medical College

Status: Not yet enrolling

Conditions: Uroepithelial Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT06663735

CHASE010

Details and patient eligibility

About

A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province

Full description

Patients diagnosed with uroepithelial carcinoma attending multiple research center hospitals in Henan Province from January 1, 2023 to December 31, 2023 A questionnaire was used to collect and analyze the treatment patterns of patients with early versus advanced uroepithelial cancer in different levels of hospitals in Henan Province.

Enrollment: 400 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults ≥18 years of age (at enrollment)
• Histologically confirmed uroepithelial carcinoma
• Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma
• Complete medical history information

Exclusion criteria

• Incomplete medical history and medical records

Trial design

400 participants in 2 patient groups

Diagnosis and management of patients with early stage resectable uroepithelial carcinoma

Description:

The study is a multicenter, non-interventional, observational cross-sectional study. It is planned to enroll patients with early stage resectable uroepithelial cancer in each study hospital in Henan Province. This is a cross-sectional study, and all patients will be anonymized for clinical data collection, and detailed information on patient demographic characteristics as well as medical and treatment history, hospitals at different stages of treatment, pathological test results, and medication regimens will be recorded at the beginning of enrollment.

Diagnosis and management of patients with advanced unresectable uroepithelial cancer

Description:

It is planned to enroll patients with advanced unresectable uroepithelial cancer in each study hospital in Henan Province. This is a cross-sectional study, and all patients will be anonymized for clinical data collection, and detailed information on patient demographic characteristics as well as medical and treatment history, hospitals at different stages of treatment, pathological test results, and medication regimens will be recorded at the beginning of enrollment.